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Abstract
Background: Videobronchoscopy is an essential diagnostic procedure for evaluation of the central airways and
pivotal for the diagnosis and staging of lung cancer. Technological improvements have resulted in high definition
(HD) images with advanced real time image enhancement techniques (i-scan).
Objectives: In this study we aimed to explore the sensitivity of HD+ i-scan bronchoscopy for detection of epithelial
changes like vascular abnormalities and suspicious preinvasive lesions, and tumors.
Methods: In patients scheduled for a therapeutic or diagnostic procedure under general anesthesia videos of the
bronchial tree were made using 5 videobronchoscopy modes in random order: normal white light videobronchoscopy
(WLB), HD-bronchoscopy (HD), HD bronchoscopy with surface enhancement technique (i-scan1), HD with surface- and
tone enhancement technique (i-scan2) and dual mode autofluorescence videobronchoscopy (AFB). The videos were
scored in random order by two independent and blinded expert bronchoscopists.
Results: In 29 patients all videos were available for analysis. Vascular abnormalities were scored most frequently in HD +
i-scan2 bronchoscopy (1.33 ± 0.29 abnormal or suspicious sites per patient) as compared to 0.12 ± 0.05 site for AFB
(P = 0.003). Sites suspicious for preinvasive lesions were most frequently reported using AFB (0.74 ± 0.12 sites per patient)
as compared to 0.17 ± 0.06 for both WLB and HD bronchoscopy (P = 0.003). Tumors were detected equally by all
modalities. The preferred modality was HD bronchoscopy with i-scan (tone- plus surface and surface enhancement in
respectively 38% and 35% of cases P = 0.006).
Conclusions: This study shows that high definition bronchoscopy with image enhancement technique may result in
better detection of subtle vascular abnormalities in the airways. Since these abnormalities may be related to
preneoplastic lesions and tumors this is of clinical relevance. Further investigations using this technique relating imaging
to histology are warranted.
Background
Bronchoscopy is one of the most important procedures
in diagnosis of lung cancer and other pulmonary dis-
eases. This procedure not only aims to obtain a diagno-
sis but also renders important anatomical information,
subtle changes in the airway epithelium and vascular
patterns of the bronchial tree are clues to guide the en-
doscopist. These subtle changes may influence the
choice of treatment, site of biopsy and resectability of
cancers when determining resection margins especially in
case of centrally located lung cancer but also in case of
multifocal premalignant disease. A meta-analysis showed
diagnostic superiority of autofluorescence bronchoscopy
(AFB) over routine white light bronchoscopy (WLB) in de-
tecting premalignant lesions [1,2]. The superiority of AFB
over WLB is especially significant in older studies using
fiber optic endoscopes, and the use of video endoscopes
further improved detection [3-5]. Yet AFB is not widely* Correspondence: erik.vanderheijden@radboudumc.nl
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used and available in specialized centers only. Further-
more, the latest version of American College of Chest
Physicians (ACCP) guideline does not strongly advocate
its use but recommends using AF ‘when available’ [6].
This weak advice is mainly due to uncertainty on the
natural history and the risk of progression from prema-
lignant lesions to invasive carcinoma and the high rate
of false positive findings that need biopsy [6]. Currently,
normal video white light bronchoscopy is the standard
in most countries and video-autofluorescence bron-
choscopy (AFB) is offered by specialized centers only.
Alternatively, the use of filters transmitting only part
of the reflected white light (narrow band imaging, NBI)
has been shown to be of additional value to detect an-
giogenic squamous dysplasia (as a precursor for invasive
tumors) [7-9] and was reported to be approximately
equal to (video-)AFB in terms of sensitivity and slightly
better specificity [10,11]. The type of vascular pattern
was also related to histological subtype (dotted vessels
related to adenocarcinoma and abrupt vessel endings to
squamous carcinoma) [12].
Through technological improvement new techniques
have become available in the form of high-definition
(HD-) bronchoscopy. Furthermore, in combination with
improved video processor unit this HD bronchoscope of-
fers real time image enhancement (i-scan Technology)
[13]. The impact of this development with high-definition
videobronchoscopy using a 1.1 megapixel chip on the diag-
nostic performance of bronchoscopy is however unknown.
In this exploratory study we therefore aim to compare
the sensitivity of HD bronchoscopy, with or without sur-
face enhancement or tone enhancement to video-AFB
(the ‘gold standard’ for preinvasive lesions) and standard
WLB for detecting abnormalities of the tracheobronchial
tree in patients with known or suspected lung cancer,
centrally located pulmonary metastatic disease or head
and neck cancer.
Methods
This study is a randomized observational exploratory
study with a blinded post procedure analysis of the diag-
nostic performance of HD bronchoscopy with or without
i-scan image enhancement technology in comparison to
standard WLB and video AFB.
Study population
Patients scheduled for diagnostic or therapeutic procedure
under general anesthesia were eligible for this exploratory
study. Ineligibility criteria are known contraindications for
diagnostic bronchoscopy (bleeding disorders, indication
for use of anticoagulant therapy (acenocoumarol, warfar-
ine, therapeutic dose of low molecular weight heparine or
clopidrogel); known allergy for lidocaine; known pulmon-
ary hypertension; recent and/or uncontrolled cardiac
disease; the presence of contraindications for the use of la-
ryngeal mask (anatomical abnormalities, increased risk for
intubation (malampatti score 4)); ASA classification greater
than or equal to 4; age under 18 years or pregnancy.
Study procedure
Prior to the scheduled procedure the bronchoscopy
studies were performed by an experienced chest phys-
ician through a laryngeal mask under general anaesthe-
sia. For bronchoscopic evaluation five different imaging
modes were used for evaluation of the central airways in
a standardized order. After each evaluation the tip of the
bronchoscope was retracted above the vocal cords. The
order of the different modes was randomized to prevent
bias due to scope or coughing induced epithelial lesions
and to prevent operator bias. The five imaging modes
used in this study are: Standard white light video-
bronchoscopy (WLB, using Pentax EB1570 in combin-
ation with Pentax EPKi7000 videoprocessor in basic
setting); High Definition (HD-) bronchoscopy (HD,
using Pentax EB1990i with EPKi-7000 videoprocessor in
basic setting); HD-bronchoscopy + surface enhancement
(i-scan 1: using Pentax EB1990i and EPKi-7000 with set-
tings brightness +0 average, redness 0, enhancement
level +4 surface enhancement +4, tone enhancement
off, color enhancement off, noise reduction low); HD-
bronchoscopy + tone enhancement (i-scan2: using
Pentax EB1990i and EPKi-7000 with settings brightness
+1 average, redness 0, enhancement level +4 surface en-
hancement +4, tone enhancement colon, color enhance-
ment off, noise reduction low) and Auto Fluorescence
Bronchoscopy (AFB – using Pentax EB1970A) in dual
video mode (simultaneous image of xenon white light
and autofluorescence light source with a laser at wavelength
408 nm and laser power 20 to 40 mW in a Pentax SAFE-
3000 videoprocessor). Depending on the randomization
order, changing of the bronchoscopes and videoprocessors
was needed.
High-definition digital videos were made from all proce-
dures without in screen indications of date, time or refer-
ence to patient identification. Clinically relevant newly
discovered abnormalities were biopsied after completion
of the study protocol upon decision of the operator.
The HD-digital video’s were reviewed separately by
two experienced bronchoscopists (WH and OS) in ran-
dom order (mixing all possible modalities and patients)
and blinded for patient information and outcome and
study date and scored using a predefined scoring system
to count vascular abnormal and sites suspicious preinva-
sive lesions and tumors sites using the scoring system
described in earlier studies with AFB and vascular pat-
terns [3,4,9,10,14]. Sites characterized by subtle vascular
changes were classified as suspicious following criteria by
Herth and Shibuya et al. [9,10] whereas sites suspected for
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preinvasive lesions were classified based on mucosal ir-
regularities and in case of AFB loss of autofluorescence
at the AF image with or without apparent abnormalities
on the twin mode WLB of the SAFE300 system as de-
scribed by Divisi, Haussinger and Ikeda et al. [3,4,14].
Average scores of the total number of abnormal and
suspicious sites per patient were used for further ana-
lysis. A joined reading was performed with disclosure of
the diagnosis in order to determine the subjectively pre-
ferred imaging modality.
This study was performed at Radboud University Medical
Center, a tertiary care university referral center between
December 2012 and October 2013. This study was ap-
proved by the RadboudUMC Medical Ethical committee
under number 2011/554 and registered on clinicaltrials.gov
with identifier: NCT01676012.
i-scan image enhancement technology
In this study i-scan surface enhancement and tone en-
hancement imaging were used with the above mentioned
settings and decribed by Kodashima and Fujishiro [13].
Surface enhancement is obtained real life by enhancing
the luminance intensity of pixels to surrounding pixels
with an adapted noise erasure algorithm. This results in
an enhancement of edge accentuating of minute struc-
tural differences. Tone enhancement is obtained by dis-
integrating the RGB components of the endoscope
image into separate components and reconstruct the
image with converted tone curves [13].
Statistics
Repeated measurements analysis was used to compare
the mean number of registered sites for each modality
with LSD posthoc testing and Chi-Square for the pre-
ferred modality. A P value of < 0.05 is considered statisti-
cally significant. Statistical analysis was performed with
SPSS 20.0 software (IBM SPSS, Chicago, Il).
Results
Of the 36 patients eligible for this study, bronchoscopy
was performed in 31 patients and a complete set of vid-
eos was available for analysis in 29 patients (Figure 1).
The mean age of the study population was 63 years
(range 40 – 93 yr), 39% were females. The majority of
the investigated patients were referred for an interven-
tional pulmonary endoscopic treatment or diagnostic
procedure (n = 24), all others were referred for a surgical
procedure by the head and neck surgeon. Of the ana-
lyzed patients non-small cell lung cancer (NSCLC) was
the most frequent condition (n = 16; 52%); five were re-
ferred for a head and neck diagnostic procedure (16%)
and one for a suspected combined NSCLC and laryngeal
cancer. The remaining patients were scheduled for a inter-
ventional pulmonary procedure for metastatic colorectal
cancer (n = 2), metastatic renal cell cancer (n = 2), melan-
oma (n = 1), lymphoma (n = 1) benign tracheal stenosis
(n = 2) and sarcoidosis (n = 1). In one of the patients with
a head and neck cancer a clinically relevant new lesion
was detected that needed biopsy which showed NSCLC.
Representative bronchoscopy images indicating the differ-
ences between the used bronchoscopy modalities is pre-
sented in Figure 2.
Number of vascular abnormalities detected
Using the different modalities for bronchoscopy the number
of vascular abnormal and suspicious lesions detected varied
from 0.12 ± 0.05 for AFB to 1.33 ± 0.29 for i-scan2 (P =
0.003, Table 1, Figure 3). Using normal WLB 0.28 ± 0.08 vas-
cular abnormal sites were detected and HD and i-scan1 de-
tected 0.72 ± 0.17 and 0.78 ± 0.22 lesions respectively.
Number of (suspected) preinvasive lesions detected
The number of sites abnormal and suspected sites for
(possible) preinvasive lesions using the different modalities
for bronchoscopy ranged from 0.17 ± 0.06 for both
WLB and HD bronchoscopy to 0.74 ± 0.12 for AFB (P =
0.001, Table 1, Figure 4). Using normal i-scan1 and i-
scan 2 0.24 ± 0.07 and 0.21 ± 0.06 possible preinvasive
lesions were detected respectively.
Figure 1 Consort flow chart of patients included the study.
HNC: head and neck cancer referral patients.
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Figure 2 Representative bronchoscopy images from two patients using (from top to bottom) normal white light videobronchoscopy
(WLB, panels a and f); HD-bronchoscopy (panels b and g); HD+ i-scan 1: HD bronchoscopy with surface enhancement (panels c and h);
HD+ i-scan2: HD bronchoscopy with surface- and tone enhancement (panels d and i) and autofluorescence bronchoscopy (AFB) in twin
mode with WLB image on the left and AFB on the right (panels e and j). The bronchoscopic images on the left are from a patient with a
(recurrent) squamous cell non small cell lung carcinoma in the mid trachea on the left lateral wall. The images on the on the right show a
abnormal vascular pattern. Pathology from this site showed squamous metaplasia, some fibrosis and signs of active inflammation.
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Number of tumor sites detected
The average number of tumor sites detected per patient
did not significantly differ between bronchoscopy modes
and ranged from 1.0 ± 0.22 in AFB to 1.22 ± 0.28 for WLB.
Using the other modalities also approximately 1 tumor site
in each patient was discovered (P = 0.488, Table 1).
Preferred modality
In a joint reading with disclosure of the medical out-
come the preferred modality was HD bronchoscopy with
i-scan image enhancement (P = 0.006). HD + i-scan 2
was preferred in 38% of the cases and HD + i-scan 1 was
the preferred modality in 35% of the cases (Figure 5).
Discussion
This randomized and blinded prospective exploratory
study indicates that the superior image quality of HD
bronchoscopy, especially in combination with i-scan image
enhancement may improve the detection of vascular abnor-
malities. For possible preinvasive lesions AFB seems to be
preferred over normal WLB and HD-bronchoscopy but in
this exploratory study no routine biopsies were obtained for
histological confirmation. For the detection of endobron-
chial tumor sites no differences were observed. These re-
sults warrant further investigation with histological
confirmation of lesions with abnormal vascular patterns.
Table 1 Number of sites detected (average per patient)
Vascular Suspicious preinvasive Tumor
Modality
WLB 0,28±0,08 0,17±0,06 1,22±0,28
HD 0,72±0,17 0,17±0,06 1,05±0,21
HD-i-scan1 0,78±0,22 0,24±0,07 1,07±0,24
HD-i-scan2 1,33±0,29* 0,21±0,06 1,03±0,22
AFB 0,12±0,05 0,74±0,12* 1,00±0,23
P *0.003 *0.001 0.488
*significant P value.
Figure 3 Number of sites with abnormal and suspicious
vascular changes. WLB: standard white light bronchoscopy; HD:
High Definition bronchoscopy; i-scan1: HD bronchoscopy with
surface enhancement; i-scan2: HD bronchoscopy with tone
enhancement; AFB: autofluorescence video bronchoscopy twin
mode (dual image SAFE3000).
Figure 4 Number of sites with suspicious preinvasive lesions.
WLB: standard white light bronchoscopy; HD: High Definition
bronchoscopy; i-scan1: HD bronchoscopy with surface enhancement;
i-scan2: HD bronchoscopy with tone enhancement; AFB:
autofluorescence video bronchoscopy dual image mode (SAFE3000).
Figure 5 Preferred modality determined in joined reading
expressed as percentage of total. WLB: standard white light
bronchoscopy; HD: High Definition bronchoscopy; i-scan1: HD
bronchoscopy with surface enhancement; i-scan2: HD bronchoscopy
with tone enhancement; AFB: autofluorescence video bronchoscopy
dual image mode (SAFE3000).
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This study shows that the use of i-scan image en-
hancement technology in combination with HD bron-
choscopy significantls improves detection of vascular
changes especially with i-scan2 offering the combination
of surface enhancement and tone enhancement render-
ing a sharp and naturally colored image of the bronchial
tree. Vascular changes have been shown to be correlated
to angiogenic squamous metaplasia and lung adenocar-
cinoma or squamous carcinoma, as was reported earlier
in studies using the narrow band filtering image tech-
nique (NBI) [7-12]. Therefore facilitation of detection of
these subtle changes is of clinical importance. It is likely
that improvement of the image quality and additional
image enhancement technology may improve the overall
diagnostic yield of bronchoscopy and improve staging
depending on the specificity and percentage of false
positive findings in future studies. Furthermore better
imaging may reduce procedure time when these tech-
niques become widely available in bronchoscopes
designed for everyday use with adequate working
channel diameters.
Additionally, it may be possible that these improved
imaging techniques may further reduce the need for
AFB. This study indicates that AFB may still be the most
sensitive modality for detecting sites suspicious for pre-
invasive lesions by the lack of autofluorescence in com-
bination with normal WLB indicating thickening of the
epithelial layer, but since there was no histological con-
firmation, this result must be interpreted with great cau-
tion. In this study AFB was used in the dual video
(“twin-mode”) setting offering direct comparison be-
tween WLB and AFB. The readers are experienced and
trained to detect lesions that lack autofluorescence with-
out gross changes on the WLB image whereas in the
other modalities only irregularity of the bronchial mu-
cosa could be classified as suspicious preinvasive lesions.
For daily clinical use AFB is only limited available and
has shown to have a low specificity with false positive
imaging up to one third of the detected lesions [2]. For
AFB a dedicated (laser) light source is needed emitting a
light at a specific wave length, usually at the 390–
440 nm range. This additional technology requirement
in combination with decreasing prevalence of centrally
located tumors has probably played a role in its low
availability in clinical practice. Therefore the use of a
single light source (emitting full spectrum white light) in
combination with filtering techniques like NBI or post
processing real time image enhancement techniques like
i-scan will be much easier to implement into daily clin-
ical practice. Furthermore recent evidence comparing
AFB to NBI has shown equal sensitivity and slightly bet-
ter specificity favoring NBI over AFB [10,11]. This is
supported by our finding that the preferred image mo-
dality in this study was the HD-bronchoscopy with
either i-scan settings based on joined reading. Apparently
a more natural colored image is preferred over the blue
images from AFB even by experienced bronchoscopist.
Conclusion
This exploratory study shows that high definition bron-
choscopy with image enhancement technique may result
in better detection of subtle vascular abnormalities in
the airways. Since these abnormalities may be related to
preneoplastic lesions and tumors this is of clinical rele-
vance. Further investigations using this technique relat-
ing imaging to histology are warranted.
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